These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 32245294)

  • 1. Immunological Responses against HER2-targeted Idarubicin-ZHER2 Conjugate in BALB/c Mice.
    Siavoshinia L; Jamalan M; Zeinali M; Mohammadzadeh G
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):501-510. PubMed ID: 32245294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate.
    Ghanemi M; Pourshohod A; Ghaffari MA; Kheirollah A; Amin M; Zeinali M; Jamalan M
    Curr Cancer Drug Targets; 2019; 19(1):65-73. PubMed ID: 28460618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by Z
    Siavoshinia L; Jamalan M; Zeinali M; Pourshohod A; Koushki M; Moradipoodeh B; Mohammadzadeh G
    Iran J Pathol; 2021; 16(2):109-118. PubMed ID: 33936221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial in silico and in vivo evaluation of immune response elicitation by the affibody Z
    Siavoshinia L; Kheirollah A; Zeinali M; Barzegari E; Jamalan M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108368. PubMed ID: 34857479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-Z
    Moradipoodeh B; Jamalan M; Zeinali M; Fereidoonnezhad M; Mohammadzadeh G
    Mol Biol Rep; 2020 Sep; 47(9):7139-7151. PubMed ID: 32929653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
    Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
    J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model.
    Jiao H; Zhao X; Liu J; Ma T; Zhang Z; Zhang J; Wang J
    Nucl Med Biol; 2019; 68-69():31-39. PubMed ID: 30578135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the first
    Honarvar H; Müller C; Cohrs S; Haller S; Westerlund K; Karlström AE; van der Meulen NP; Schibli R; Tolmachev V
    Nucl Med Biol; 2017 Feb; 45():15-21. PubMed ID: 27837664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and imaging assessment of the HER2-targeting chemotherapy drug Z
    Han J; Zhao Y; Zhao X; Ma T; Hao T; Liu J; Zhang Z; Zhang J; Wang J
    Invest New Drugs; 2020 Aug; 38(4):1031-1043. PubMed ID: 31758360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.
    Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V
    J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Affibody-Auristatin E Conjugate With a Potent and Selective Activity Against HER2+ Cell Lines.
    Sochaj-Gregorczyk AM; Serwotka-Suszczak AM; Otlewski J
    J Immunother; 2016; 39(6):223-32. PubMed ID: 27227324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors.
    Altai M; Liu H; Ding H; Mitran B; Edqvist PH; Tolmachev V; Orlova A; Gräslund T
    J Control Release; 2018 Oct; 288():84-95. PubMed ID: 30172673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.
    Xiao Z; Juan L; Song Y; Zhijian Z; Jing J; Kun Y; Yuna H; Dongfa D; Lili D; Liuxin T; Fei L; Nan L; Fang Y; Yuying S; Yongzhi X
    Hum Vaccin Immunother; 2015; 11(4):938-45. PubMed ID: 25763999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice.
    Hop HT; Simborio HL; Reyes AW; Arayan LT; Min W; Lee HJ; Kim DH; Chang HH; Kim S
    FEMS Microbiol Lett; 2015 Feb; 362(4):. PubMed ID: 25724777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HER2 Affibody-Conjugated Photosensitizer for Tumor Targeting Photodynamic Therapy.
    Li S; Jin Y; Su Y; Li W; Xing Y; Wang F; Hong Z
    Mol Pharm; 2020 May; 17(5):1546-1557. PubMed ID: 32267710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 promotes the induction of immunoglobulin production after inhalation of house dust mite extract in mice.
    Canbaz D; Utsch L; Logiantara A; van Ree R; van Rijt LS
    Allergy; 2015 May; 70(5):522-32. PubMed ID: 25676669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses.
    Bolhassani A; Kardani K; Vahabpour R; Habibzadeh N; Aghasadeghi MR; Sadat SM; Agi E
    Immunol Lett; 2015 Dec; 168(2):366-73. PubMed ID: 26518142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment.
    Altai M; Wållberg H; Honarvar H; Strand J; Orlova A; Varasteh Z; Sandström M; Löfblom J; Larsson E; Strand SE; Lubberink M; Ståhl S; Tolmachev V
    J Nucl Med; 2014 Nov; 55(11):1842-8. PubMed ID: 25278516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice.
    Doosti M; Nassiri M; Nasiri K; Tahmoorespur M; Zibaee S
    Microb Pathog; 2019 Jul; 132():30-37. PubMed ID: 31004723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fermented soybean powder with rice mold in the absence of salt stimulates the cellular immune system and suppresses the humoral immune response in mice.
    Karasawa K; Sugiura Y; Kojima M; Uzuhashi Y; Otani H
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(6):564-9. PubMed ID: 24477255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.